Measured Wealth Private Client Group’s Chemours CC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$21 Hold
1
﹤0.01% 688
2026
Q1
$22 Hold
1
﹤0.01% 695
2025
Q4
$12 Hold
1
﹤0.01% 716
2025
Q3
$16 Buy
+1
New +$15 ﹤0.01% 681
2022
Q4
Sell
-8,327
Closed -$205K 165
2022
Q3
$205K Sell
8,327
-1,171
-12% -$38.6K 0.09% 142
2022
Q2
$304K Sell
9,498
-1,389
-13% -$51.1K 0.13% 115
2022
Q1
$343K Buy
10,887
+978
+10% +$30.6K 0.13% 99
2021
Q4
$333K Sell
9,909
-1,594
-14% -$49.7K 0.12% 106
2021
Q3
$334K Sell
11,503
-2,685
-19% -$86.9K 0.13% 108
2021
Q2
$494K Buy
14,188
+1,198
+9% +$39.7K 0.16% 80
2021
Q1
$363K Sell
12,990
-1,179
-8% -$31.4K 0.13% 98
2020
Q4
$351K Buy
14,169
+615
+5% +$14.6K 0.15% 81
2020
Q3
$283K Sell
13,554
-2,791
-17% -$53.9K 0.14% 92
2020
Q2
$251K Buy
16,345
+3,154
+24% +$39.9K 0.15% 88
2020
Q1
$117K Buy
+13,191
New +$190K 0.09% 99
2018
Q4
Sell
-100
Closed -$4K 192
2018
Q3
$4K Buy
+100
New +$4.38K ﹤0.01% 711

Other funds holding CC

Measured Wealth Private Client Group's CC Position: Q2 2026 in Review

Measured Wealth Private Client Group held its Chemours (CC) position steady in Q2 2026 at 1 share worth $21. The position accounts for ﹤0.01% of the portfolio, ranked #688.

Measured Wealth Private Client Group first reported a position in CC in Q3 2018 and has held it in 16 quarters since. The position peaked at $494K in Q2 2021. 469 funds tracked by Wall St. Rank hold CC as of Q2 2026.

  • Measured Wealth Private Client Group held 1 share of Chemours worth $21 as of Q2 2026.
  • Measured Wealth Private Client Group left its Chemours share count unchanged in Q2 2026.
  • Chemours made up ﹤0.01% of Measured Wealth Private Client Group's portfolio in Q2 2026, its #688 holding.
  • Measured Wealth Private Client Group first reported a position in Chemours in Q3 2018 and has held it in 16 quarters since.
  • Measured Wealth Private Client Group's Chemours position peaked at $494K in Q2 2021.
  • 469 funds tracked by Wall St. Rank held Chemours as of Q2 2026.

Based on Measured Wealth Private Client Group's 13F filing for Q2 2026, filed 10 Aug 2026.